System Transmission

Top Signal

100#1 JOB

Activity

2177Ripe

+933 today

System

Live1m

Terminal Asset View

stockNASDAQ

AGEN

$3.10+4.03%

Agenus Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

70Ripe

Live Analysis Active

Company Mission

Agenus Inc creates cancer therapies that help the body's immune system fight tumors. Hospitals and patients use these treatments because they target cancer cells more precisely than traditional methods. The company makes money by selling its approved drugs and partnering with other firms to develop new medicines.

AGE

Industry Context

This company operates in the biotechnology sector, focusing on developing innovative treatments for diseases like cancer. It competes with larger pharmaceutical firms by specializing in immune-based therapies, which are gaining traction due to their potential for fewer side effects. The industry is highly regulated, requiring extensive clinical trials before products can reach the market.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

78Matrix

Market Momentum

50.9— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

4.03%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing AGEN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 09:06 AM UTC

As-of As of 2026-03-15T08:51:14.548Z UTC (~15m delay).

Develops cancer-fighting drugs that help the body's immune system attack tumors, generating revenue through partnerships and potential future drug sales.

Weekly range is narrowing near $2, often a precursor to a significant breakout or breakdown. Watch for price breaking above or below this level.

No technical indicators available, but monitor if price holds above $2, signaling potential stability. Watch for any new data releases.

Industry trend in biotech is driving interest, with focus on immunotherapy advancements, signaling growth opportunities. Watch for sector momentum and regulatory updates.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...